An unusual case of Erysipelothrix rhusiopathiae prosthetic joint infection from the Canadian Arctic: whole genome sequencing unable to identify a zoonotic source.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
25 Mar 2019
Historique:
received: 12 09 2018
accepted: 17 03 2019
entrez: 27 3 2019
pubmed: 27 3 2019
medline: 1 5 2019
Statut: epublish

Résumé

Erysipelothrix rhusiopathiae is a zoonotic pathogen that causes erysipeloid and is most frequently associated with exposure to domestic swine. Infection of native and prosthetic joints is a rarely reported manifestation. We describe a case of E. rhusiopathiae prosthetic joint infection in a woman with a history of exposure to wild animals in the Canadian Arctic. Patient management involved a 1-stage surgical revision exchange with an antibiotic impregnated cement spacer and 6 weeks of intravenous penicillin G followed by 6 weeks of oral amoxicillin. Ten previously reported cases of E. rhusiopathiae joint infection are reviewed. Recent increases in mortality due to infection with this organism among host animal populations in the Canadian Arctic have generated concern regarding a potential increase in human infections. However, whole genome sequencing (WGS) of the organism was unable to identify a zoonotic origin for this case. Consideration should be given to E. rhusiopathiae as a cause of joint infections if the appropriate epidemiologic and host risk factors exist. Expanded use of WGS in other potential animal hosts and environmental sources may provide important epidemiologic information in determining the source of human infections.

Sections du résumé

BACKGROUND BACKGROUND
Erysipelothrix rhusiopathiae is a zoonotic pathogen that causes erysipeloid and is most frequently associated with exposure to domestic swine. Infection of native and prosthetic joints is a rarely reported manifestation.
CASE PRESENTATION METHODS
We describe a case of E. rhusiopathiae prosthetic joint infection in a woman with a history of exposure to wild animals in the Canadian Arctic. Patient management involved a 1-stage surgical revision exchange with an antibiotic impregnated cement spacer and 6 weeks of intravenous penicillin G followed by 6 weeks of oral amoxicillin. Ten previously reported cases of E. rhusiopathiae joint infection are reviewed. Recent increases in mortality due to infection with this organism among host animal populations in the Canadian Arctic have generated concern regarding a potential increase in human infections. However, whole genome sequencing (WGS) of the organism was unable to identify a zoonotic origin for this case.
CONCLUSIONS CONCLUSIONS
Consideration should be given to E. rhusiopathiae as a cause of joint infections if the appropriate epidemiologic and host risk factors exist. Expanded use of WGS in other potential animal hosts and environmental sources may provide important epidemiologic information in determining the source of human infections.

Identifiants

pubmed: 30909869
doi: 10.1186/s12879-019-3913-7
pii: 10.1186/s12879-019-3913-7
pmc: PMC6434803
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

282

Subventions

Organisme : National Sciences and Engineering Research Council of Canada
ID : Discovrery Grant

Références

J Med Microbiol. 1999 Sep;48(9):789-99
pubmed: 10482289
J Clin Microbiol. 2000 Mar;38(3):1302-4
pubmed: 10699048
Pathology. 2002 Oct;34(5):462-5
pubmed: 12408347
Arthroscopy. 2003 Mar;19(3):E26
pubmed: 12627143
Arthritis Rheum. 2003 Apr;48(4):1156-7
pubmed: 12687560
Lupus. 2003;12(4):324-6
pubmed: 12729059
Methods Mol Biol. 2004;268:199-205
pubmed: 15156031
Lancet. 2006 Mar 11;367(9513):859-69
pubmed: 16530580
CMAJ. 2008 Mar 11;178(6):715-22
pubmed: 18332386
J Arthroplasty. 2008 Jun;23(4):609-11
pubmed: 18514883
J Arthroplasty. 2010 Apr;25(3):497.e21-3
pubmed: 19195828
Lancet Infect Dis. 2009 Jun;9(6):365-75
pubmed: 19467476
Clin Exp Dermatol. 2009 Dec;34(8):859-62
pubmed: 19663854
Vet Microbiol. 2010 Jan 27;140(3-4):405-17
pubmed: 19733019
J Clin Microbiol. 2010 Jan;48(1):333-5
pubmed: 19923477
Am Fam Physician. 2011 Sep 15;84(6):653-60
pubmed: 21916390
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
Asian Pac J Trop Biomed. 2012 Jun;2(6):503-4
pubmed: 23569959
Curr Rheumatol Rep. 2013 Jun;15(6):332
pubmed: 23591823
Can Vet J. 2015 Jun;56(6):560-3
pubmed: 26028673
Clin Microbiol Rev. 1989 Oct;2(4):354-9
pubmed: 2680056
Infect Dis Rep. 2016 Mar 21;8(1):6368
pubmed: 27103974
BMC Genomics. 2016 Jun 14;17:461
pubmed: 27301771
Vet Pathol. 2017 Mar;54(2):258-268
pubmed: 27543449
Front Microbiol. 2016 Nov 07;7:1759
pubmed: 27872617
Med Mal Infect. 2018 Aug;48(5):372-373
pubmed: 29656843
Rev Infect Dis. 1988 Mar-Apr;10(2):317-25
pubmed: 3287562
Enferm Infecc Microbiol Clin. 1996 Aug-Sep;14(7):452-3
pubmed: 8991446

Auteurs

Michael Groeschel (M)

Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. michael.groeschel@cls.ab.ca.

Taya Forde (T)

Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK.

Shannon Turvey (S)

Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta, 3B20-11111 Jasper Avenue, Edmonton, AB, T5K 0L4, Canada.

A Mark Joffe (AM)

Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta, 3B20-11111 Jasper Avenue, Edmonton, AB, T5K 0L4, Canada.

Catherine Hui (C)

Division of Orthopaedic Surgery, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Prenilla Naidu (P)

Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.

Fabien Mavrot (F)

Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.

Susan Kutz (S)

Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.

Ameeta E Singh (AE)

Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta, 3B20-11111 Jasper Avenue, Edmonton, AB, T5K 0L4, Canada. ameeta@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH